Is Biogen Going to Move Beyond Its MS Franchise?

This is a company that's struggled to move beyond its MS franchise. Is there a reason to think activity will pick up in 2023? That's the perennial question, right? You ask everybody, like, what do you think M&A activity will be in the next 12 months? And the answer to those survey questions is always there will be more, right? But does that necessarily mean that we'll see deals? Like, who knows?"

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.